Antibody Engineering for Targeted Therapy of Cancer Recombinant Fv-Immunotoxins
Journal:
Current Pharmaceutical Biotechnology
Volume:
2
Page:
19-46
Author(s):
Revital Niv, Cyril J. Cohen, Galit Denkberg, Dina Segal and Yoram Reiter
Protein Kinase C as a Drug Target Implications for Drug or Diet Prevention and Treatment of Cancer
Journal:
Current Drug Targets
Volume:
1
Page:
163-183
Author(s):
Charleata A. Carter
Toward The Rational Design of Cell Fate Modifiers Notch Signaling as a Target for Novel Biopharmaceuticals
Journal:
Current Pharmaceutical Biotechnology
Volume:
1
Page:
83-106
Author(s):
A. Zlobin, M. Jang and L. Miele